Ambulatory Pharmaceutical Services Inactive
Filed: 27 Jul 12, 12:00am
| UNITED STATES | OMB APPROVAL |
| SECURITIES AND EXCHANGE | OMB Number: 3235-0167 |
|
|
|
| FORM 15 |
|
CERTIFICATION AND NOTICE OF TERMINATION OF REGISTRATION UNDER SECTION 12(g) OF THE SECURITIES EXCHANGE ACT OF 1934 OR SUSPENSION OF DUTY TO FILE REPORTS UNDER SECTIONS 13 AND 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934.
Commission File Number 333-162227-17 |
|
333-132017-50 |
|
Ambulatory Pharmaceutical Services, Inc.
(Exact name of registrant as specified in its charter)
See Schedule A for Additional Registrants
1300 Morris Drive
Chesterbrook, PA 19087
(610) 727-7000
(Address, including zip code, and telephone number, including area code, of registrant’s principal executive offices)
Guarantee of 5 5/8% Senior Notes due 2012
Guarantee of 5 7/8% Senior Notes due 2015
Guarantee of 4.875% Senior Notes due 2019
Guarantee of 3.500% Senior Notes due 2021
Guarantees of Debt Securities
(Title of each class of securities covered by this Form)
None
(Titles of all other classes of securities for which a duty to file reports under section 13(a) or 15(d) remains)
Please place an X in the box(es) to designate the appropriate rule provision(s) relied upon to terminate or suspend the duty to file reports:
| Rule 12g-4(a)(1) | o |
|
|
|
|
| Rule 12g-4(a)(2) | o |
|
|
|
|
| Rule 12h-3(b)(1)(i) | x |
|
|
|
|
| Rule 12h-3(b)(1)(ii) | o |
|
|
|
|
| Rule 15d-6 | o |
|
|
|
|
|
|
|
|
|
|
|
Approximate number of holders of record as of the certification or notice date: None.*
* On June 29, 2012, each of the registrants was released and relieved from its obligations under its Guarantee of 5 5/8% Senior Notes due 2012, Guarantee of 5 7/8% Senior Notes due 2015, Guarantee of 4.875% Senior Notes due 2019 and Guarantee of 3.500% Senior Notes due 2021 (collectively, the “Guarantees”) and the Guarantees were terminated. Accordingly, all of the Guarantees ceased to be outstanding as of June 29, 2012 and there are currently no holders of the Guarantees. Also, on July 18, 2012, the Registrant filed Post-Effective Amendment No. 4 to the Registration Statement on Form S-3 (Registration No. 333-162227) and, and upon filing of Post-Effective Amendment No. 4, the Guarantees of Debt Securities covered by such Registration Statement were de-registered.
SEC 2069 (02-08) |
| Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB control number. |
SCHEDULE A — ADDITIONAL REGISTRANTS
Exact name of registrant as specified in its charter |
| Commission |
| Address, including Zip Code |
|
|
|
|
|
AmerisourceBergen Drug Corporation |
| 333-162227-01 |
| 1300 Morris Drive |
|
|
|
|
|
AmerisourceBergen Consulting Services, Inc. |
| 333-162227-34 |
| 1300 Morris Drive |
|
|
|
|
|
AmerisourceBergen Holding Corporation |
| 333-162227-18 |
| 1300 Morris Drive |
|
|
|
|
|
AmerisourceBergen Services Corporation |
| 333-162227-10 |
| 1300 Morris Drive |
|
|
|
|
|
AmerisourceBergen Specialty Group, Inc. |
| 333-162227-08 |
| 1300 Morris Drive |
|
|
|
|
|
AmeriSource Health Services Corporation |
| 333-162227-28 |
| 1300 Morris Drive |
|
|
|
|
|
AmeriSource Heritage Corporation |
| 333-162227-27 |
| 1300 Morris Drive |
|
|
|
|
|
Anderson Packaging, Inc. |
| 333-162227-19 |
| 1300 Morris Drive |
|
|
|
|
|
APS Enterprises Holding Company, Inc. |
| 333-162227-20 |
| 1300 Morris Drive |
|
|
|
|
|
ASD Specialty Healthcare, Inc. |
| 333-162227-29 |
| 1300 Morris Drive |
|
|
|
|
|
AutoMed Technologies, Inc. |
| 333-162227-23 |
| 1300 Morris Drive |
|
|
|
|
|
Bellco Drug Corp. |
| 333-162227-07 |
| 1300 Morris Drive |
|
|
|
|
|
Clinical Outcomes Resource Application Corporation |
| 333-162227-09 |
| 1300 Morris Drive |
|
|
|
|
|
Dialysis Purchasing Alliance, Inc. |
| 333-162227-06 |
| 1300 Morris Drive |
|
|
|
|
|
Health Services Capital Corporation |
| 333-162227-26 |
| 1300 Morris Drive |
Exact name of registrant as specified in its charter |
| Commission |
| Address, including Zip Code |
|
|
|
|
|
I.G.G. of America, Inc. |
| 333-162227-05 |
| 1300 Morris Drive |
|
|
|
|
|
IHS Acquisition XXX, Inc. |
| 333-162227-21 |
| 1300 Morris Drive |
|
|
|
|
|
Imedex, LLC |
| 333-162227-22 |
| 1300 Morris Drive |
|
|
|
|
|
Integrated Commercialization Solutions, Inc. |
| 333-162227-32 |
| 1300 Morris Drive |
|
|
|
|
|
International Oncology Network Solutions, Inc. |
| 333-162227-33 |
| 1300 Morris Drive |
|
|
|
|
|
International Physician Networks, L.L.C. |
| 333-162227-04 |
| 1300 Morris Drive |
|
|
|
|
|
IntrinsiQ Holdings, Inc. |
| 333-162227-38 |
| 1300 Morris Drive |
|
|
|
|
|
IntrinsiQ, LLC |
| 333-162227-37 |
| 1300 Morris Drive |
|
|
|
|
|
Liberty Acquisition Corp. |
| 333-162227-03 |
| 1300 Morris Drive |
|
|
|
|
|
Medical Initiatives, Inc. |
| 333-162227-30 |
| 1300 Morris Drive |
|
|
|
|
|
Pharm Plus Acquisition, Inc. |
| 333-162227-16 |
| 1300 Morris Drive |
|
|
|
|
|
Pharmacy Healthcare Solutions, Ltd. |
| 333-162227-25 |
| 1300 Morris Drive |
|
|
|
|
|
Premier Source, LLC |
| 333-162227-35 |
| 1300 Morris Drive |
|
|
|
|
|
Solana Beach, Inc. |
| 333-162227-12 |
| 1300 Morris Drive |
|
|
|
|
|
Specialty Pharmacy, Inc. |
| 333-162227-14 |
| 1300 Morris Drive |
Exact name of registrant as specified in its charter |
| Commission |
| Address, including Zip Code |
|
|
|
|
|
Specialty Pharmacy of California, Inc. |
| 333-162227-13 |
| 1300 Morris Drive |
|
|
|
|
|
Telepharmacy Solutions, Inc. |
| 333-162227-31 |
| 1300 Morris Drive |
|
|
|
|
|
The Lash Group, Inc. |
| 333-162227-11 |
| 1300 Morris Drive |
|
|
|
|
|
US Bioservices Corporation |
| 333-162227-15 |
| 1300 Morris Drive |
|
|
|
|
|
Value Apothecaries, Inc. |
| 333-162227-24 |
| 1300 Morris Drive |
|
|
|
|
|
Xcenda, LLC |
| 333-162227-02 |
| 1300 Morris Drive |
Pursuant to the requirements of the Securities Exchange Act of 1934, each of the registrants has caused this certification/notice to be signed on its behalf by the undersigned duly authorized person.
Date: July 27, 2012
|
| AMERISOURCEBERGEN DRUG CORPORATION | ||
|
| AMBULATORY PHARMACEUTICAL SERVICES, INC. | ||
|
| AMERISOURCEBERGEN CONSULTING SERVICES, INC. | ||
|
| AMERISOURCEBERGEN HOLDING CORPORATION | ||
|
| AMERISOURCEBERGEN SERVICES CORPORATION | ||
|
| AMERISOURCEBERGEN SPECIALTY GROUP, INC. | ||
|
| AMERISOURCE HEALTH SERVICES CORPORATION | ||
|
| ANDERSON PACKAGING, INC. | ||
|
| APS ENTERPRISES HOLDING COMPANY, INC. | ||
|
| ASD SPECIALTY HEALTHCARE, INC. | ||
|
| AUTOMED TECHNOLOGIES, INC. | ||
|
| BELLCO DRUG CORP. | ||
|
| CLINICAL OUTCOMES RESOURCE APPLICATION CORPORATION | ||
|
| DIALYSIS PURCHASING ALLIANCE, INC. | ||
|
| HEALTH SERVICES CAPITAL CORPORATION | ||
|
| I.G.G. OF AMERICA, INC. | ||
|
| IHS ACQUISITION XXX, INC. | ||
|
| IMEDEX, LLC | ||
|
| INTEGRATED COMMERCIALIZATION SOLUTIONS, INC. | ||
|
| INTERNATIONAL ONCOLOGY NETWORK SOLUTIONS, INC. | ||
|
| INTERNATIONAL PHYSICIAN NETWORKS, L.L.C. | ||
|
| INTRINSIQ HOLDINGS, INC. | ||
|
| INTRINSIQ, LLC | ||
|
| LIBERTY ACQUISITION CORP. | ||
|
| MEDICAL INITIATIVES, INC. | ||
|
| PHARM PLUS ACQUISITION, INC. | ||
|
| PREMIER SOURCE, LLC | ||
|
| SOLANA BEACH, INC. | ||
|
| SPECIALTY PHARMACY, INC. | ||
|
| SPECIALTY PHARMACY OF CALIFORNIA, INC. | ||
|
| TELEPHARMACY SOLUTIONS, INC. | ||
|
| THE LASH GROUP, INC. | ||
|
| US BIOSERVICES CORPORATION | ||
|
| VALUE APOTHECARIES, INC. | ||
|
| XCENDA, LLC | ||
|
|
| ||
|
|
| ||
|
| By: | /s/ Tim G. Guttman | |
|
|
| Name: | Tim G. Guttman |
|
|
| Title: | Vice President, Corporate Controller and Acting Chief Financial Officer of each of the above-named registrants |
|
| PHARMACY HEALTHCARE SOLUTIONS, LTD. | ||
|
|
| ||
|
| By: | VALUE APOTHECARIES, INC., AS GENERAL PARTNER | |
|
|
|
|
|
|
|
|
|
|
|
| By: | /s/ Tim G. Guttman | |
|
|
| Name: | Tim G. Guttman |
|
|
| Title: | Vice President, Corporate Controller and Acting Chief Financial Officer |
|
|
|
|
|
|
|
|
|
|
|
| AMERISOURCE HERITAGE CORPORATION | ||
|
|
| ||
|
|
| ||
|
| By: | /s/ Daniel T. Hirst | |
|
|
| Name: | Daniel T. Hirst |
|
|
| Title: | Vice President and Treasurer |
Instruction: This form is required by Rules 12g-4, 12h-3 and 15d-6 of the General Rules and Regulations under the Securities Exchange Act of 1934. The registrant shall file with the Commission three copies of Form 15, one of which shall be manually signed. It may be signed by an officer of the registrant, by counsel or by any other duly authorized person. The name and title of the person signing the form shall be typed or printed under the signature.